Trials / Completed
CompletedNCT06422182
Erector Spinae Plane Block in Radical Cystectomy
Ultrasound-Guided Erector Spinae Plane Block in Radical Cystectomy: A Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Kafrelsheikh University · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this research is to study and compare the efficacy and safety of bilateral single injection erector spinae plane block (ESPB) compared with intravenous patient-controlled analgesia (IV-PCA) in managing postoperative pain after radical cystectomy.
Detailed description
Radical cystectomy (RC) is one of the most challenging surgical techniques in Urology. Acute postsurgical pain is frequently detrimental in a patient's recovery and quality of life. Intravenous patient-controlled analgesia (IV-PCA) is one of the most commonly used strategies in clinical practice for controlling postoperative pain. It involves continuous administration of a programmed dose of analgesics, while also allowing patients to receive additional, need-based doses. One such avenue is the erector spinae plane block (ESPB), a novel analgesic technique first described in 2016 by Forero et al. Although the mechanism of action of the ESPB is unknown, a proposed mechanism is via blockade of the dorsal and ventral rami of thoracic/lumbar spinal nerves. ESPB has been used as analgesia in rib fractures and other thoracic procedures as well as in abdominal surgeries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bupivacain 25% (Erector Spinae Plane Block) | Patients received ultrasound guided bilateral single shot erector spinae pane block (ESPB) at Th10 level with 20 mL 0.25% bupivacaine after the end of surgery. |
| DRUG | Morphine (Intravenous patient-controlled analgesia) | Patients received intravenous patient-controlled analgesia (IV-PCA) by morphine |
Timeline
- Start date
- 2021-07-25
- Primary completion
- 2024-01-15
- Completion
- 2024-01-15
- First posted
- 2024-05-20
- Last updated
- 2024-05-21
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06422182. Inclusion in this directory is not an endorsement.